Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
10.1371/journal.pone.0267475
Saved in:
Main Authors: | Zhang, X, Ng, YY, Du, Z, Li, Z, Chen, C, Xiao, L, Chng, WJ, Wang, S |
---|---|
Other Authors: | BIOLOGICAL SCIENCES |
Format: | Article |
Published: |
Public Library of Science (PLoS)
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/228995 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
EVALUATION OF NOVEL ANTIBODIES FOR CHIMERIC ANTIGEN RECEPTOR T CELL APPLICATIONS
by: LEONARD WEN YAN LEONG
Published: (2021) -
Electroporation of NKG2D RNA CAR Improves V?9V?2 T Cell Responses against Human Solid Tumor Xenografts
by: Ang, W.X., et al.
Published: (2021) -
CD28 CO-STIMULATION AND CANCER IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR-MODIFIED NATURAL KILLER CELLS
by: YANG CHIYUN
Published: (2018) -
CAR T-cell therapy in multiple myeloma: more room for improvement
by: Teoh, Phaik Ju, et al.
Published: (2021) -
IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY
by: NATASHA VINANICA
Published: (2020)